Pillar 3
- OUR PROMISE
We advocate for people-centered healthcare systems
Behind every healthcare policy is a person waiting for care. In moments of economic strain, healthcare systems may view health spending as a cost to be minimized. But we see health as an investment, a crucial contributor to social and economic well-being and a key area for innovation.
L-R: Míriam Gifre, Corporate and digital communications with Clàudia Fernández-Arévalo, Corporate Affairs Graduate, Spain © Jordi Salas
What does meaningful patient engagement in decision-making look like in practice? We prioritize consistent partnership with patients to capture real-world disease data and integrate patient experience into our regulatory submissions and reimbursement dossiers. This helps to foster meaningful multi-stakeholder dialogue across all healthcare systems about the issues that matter most to patients.
As we progress further into 2026, we are focused on addressing healthcare policy through co-created advocacy projects, ensuring patient experience and patient expertise drive change where it is needed. We are also committed to supporting regulatory submissions at the local level, ensuring patient needs and priorities are included in documentation.
100% of our Phase 3 indications have a patient relevant drug label strategy, helping patients make informed treatment decisions
77% of reimbursement dossiers across 10 countries we monitor with mature Health Technology Assessments (HTAs) included patient-based evidence
100% of Regulatory filings including patient experience as evidence in 2025
“When patient voices are integrated into policy discussions, regulatory decisions, and reimbursement processes, healthcare systems become more responsive, more equitable, and more sustainable.”